Argenx
ARGX
#422
Rank
S$72.72 B
Marketcap
S$1,168
Share price
-1.62%
Change (1 day)
39.34%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report